WeedMD Changes Third Quarter 2019 Earnings Conference Call Time to 1 p.m. EST on November 29th
WeedMD company financials and corporate update will now be filed on November 29, 2019....
28
Nov 2019
0
WeedMD.com
26
Nov 2019
WeedMD Appoints Seasoned Management Team to Lead Commercial Extraction Affiliate CX Industries.
Newly-appointed CX team includes veteran pharma leader Tricia Symmes as General Manager and skilled concentrates leader Logan Marynissen as Director of Extraction....
22
Nov 2019
WeedMD to Host Third Quarter 2019 Earnings Conference Call on November 29 at 10 a.m. Eastern Time
WeedMD company financials and corporate update will be filed after market on November 28, 2019....
05
Nov 2019
WeedMD Provides Corporate Update and Schedules Q3 2019 Earnings Call for November 29th
Company completes inaugural outdoor cannabis harvest; CX Industries enters commercial operations; Health Canada grants WeedMD approval to produce extracts, edibles & topicals....
16
Oct 2019
WeedMD Secures Health Canada Licence for 50,000-Square-Foot Purpose-Built Cannabis Processing Facility
WeedMD is pleased to announce that it has secured a Health Canada licence amendment approval for its purpose-built processing facility in Strathroy, Ontario. The stand-alone, 50,000 sq. ft. custom-built structure, located on WeedMD’s 158-acre Strathroy property, will dry, process and cure all remaining outdoor-cultivated cannabis...
27
Sep 2019
WeedMD to Host Media and VIP Open House to Showcase Harvest of its Outdoor-Cultivated Cannabis
Experiential event on Oct. 3rd spotlights Company’s unique outdoor cultivation practices....
25
Sep 2019
WeedMD Closes its $13.1 Million Bought-Deal Offering
WeedMD is pleased to announce that it has closed its previously-announced bought-deal short-form prospectus offering of convertible debenture units at a price of $1,000 per Convertible Debenture Unit for aggregate gross proceeds of $13,115,000, which includes proceeds from the over-allotment option. The Offering was led...
05
Sep 2019
WeedMD Announces Upsize of its Previously Announced Bought-Deal Offering of Convertible Debenture Units to $12 Million
WeedMD is pleased to announce that is has entered into a revised agreement with Mackie Research Capital Corporation as the lead underwriter and sole bookrunner, on its own behalf and on behalf of a syndicate of underwriters, including Haywood Securities Inc., to increase the size...
04
Sep 2019
WeedMD Announces $10 Million Bought Short Form Prospectus Offering of Convertible Debenture Units
WeedMD is is pleased to announce that is has entered into an agreement with Mackie Research Capital Corporation as the lead underwriter and sole bookrunner, on its own behalf and on behalf of a syndicate of underwriters, including Haywood Securities Inc., pursuant to which the...
28
Aug 2019
WeedMD Reports Second Quarter 2019 Financial Results
WeedMD is pleased to report its financial and operating results for the three months ended June 30, 2019, including net revenue of $8.0 million and a gross margin of 46%....
